RNS Number : 6581X
Ondo InsurTech PLC
29 December 2023
 

                                                                                                                                                29 December 2023

 

Ondo InsurTech Plc

("Ondo" or "the Company")

 

Total Voting Rights and Shares in issue update

Ondo InsurTech Plc ("Ondo"), the London-listed leader in claims prevention technology for home insurers, is pleased to provide an update on its Share in Issue and Total Voting rights in accordance with the Financial Conduct Authority's Disclosure and Transparency Rule 5.6.1,

 

Since our announcement on 30 November 2023 a further 83,333 shares have been issued pursuant to warrant exercises and these shares were admitted to trading under the Company's blocklisting arrangement.

 

The Company's issued share capital as of 29 December 2023 comprises of 86,449,362 ordinary shares of 5p each.  The Company holds no shares in treasury.

 

Each ordinary share carries the right to one vote in relation to all circumstances at general meetings of the Company.  The total number of voting rights in the Company is therefore 86,449,362.   

 

The above figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure and Transparency Rules.

 

Enquiries:

Ondo InsurTech Plc

Craig Foster, CEO

Kevin Withington, CFO

+44 (0) 800 783 9866

Dowgate Capital Ltd

(Broker & Financial Advisor)

Russell Cook

Nick Chambers

Charlie Hall

+44 (0) 20 3903 7715

 

Cassiopeia Services Ltd

(PR & Investor Relations)

Stefania Barbaglio

+44 (0) 7949 690338

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TVRLFLFLXLLZFBB